 |
FDA Approval Activities for this Drug
Bumex (bumetanide) Tablets & Bumex (bumetanide) Injection, 0.25, 1 and 2 mg & 0.25 mg/mL, respectively, Hoffmann-La Roche NDA 18-225/S-018 & 019 & 18-226/S-024 & 025 10/29/02 11/19/02 3/7/03
Bumex (bumetanide) Tablets, 0.25, 1 and 2 mg, Hoffmann-La Roche NDA 18-225/S22 BUMETANIDE Injection 0.25MG/ML BUMETANIDE Abbott 074332 BUMETANIDE Injection 0.25MG/ML BUMETANIDE Abbott 074441 BUMETANIDE Injection 0.25MG/ML BUMETANIDE Bedford 074613 BUMETANIDE Injection 0.25MG/ML BUMETANIDE Gensia Sicor 018226 BUMETANIDE Injection 0.25MG/ML BUMEX ROCHE
074700 BUMETANIDE Tablet; 0.5MG BUMETANIDE Eon 074700 BUMETANIDE Tablet; 1MG BUMETANIDE Eon 074700 BUMETANIDE Tablet; 2MG BUMETANIDE Eon 074225 BUMETANIDE Tablet; 0.5MG BUMETANIDE Ivax 074225 BUMETANIDE Tablet; 1MG BUMETANIDE Ivax 074225 BUMETANIDE Tablet; 2MG BUMETANIDE Ivax 018225 BUMETANIDE Tablet; 0.5MG BUMEX ROCHE
018225 BUMETANIDE Tablet; 1MG BUMEX ROCHE
018225 BUMETANIDE Tablet; 2MG BUMEX ROCHE
For the most up-to-date approval information, please locate this API using the drug index.
|